Addiction remains one of the most pressing health challenges. Across the world, researchers are advancing how we address substance use disorders by understanding risk factors and patterns of use, diagnosing them early with more precision, considering comorbidities, and treating them more effectively. Together, these developments are reshaping community responses and clinical practices by informing evidence-based approaches targeting prevention, treatment, recovery, and policy

The Addiction Policy Forum 10th Anniversary Reception featured thoughtful dialogue, recognition of key leaders on Capitol Hill and throughout the field, and an opportunity to celebrate progress in the field while recommitting to the work ahead. 2025 Award Winners Legislators of the Year Awards The Legislator of the Year Award is granted annually to Members of Congress who have demonstrated exceptional leadership and commitment to improving our nation’s response to the addicti

Key Facts Substance use disorders affect over 48 million Americans and remain one of the nation’s leading public health challenges, with overdose the top cause of death for adults aged 18-44. Addiction (the most severe form of a substance use disorder) is a chronic brain disease that alters the brain’s reward and control systems. Recovery is possible as brain function can heal over time with treatment and abstinence. The risk of developing an SUD stems from a mix of genetic,

7-Hydroxymitragynine (7-OH) is a psychoactive component of kratom — and it’s showing up in increasingly in new concentrate and synthetic forms in products found in gas stations and convenience stores. These newer formulations have increased concerns among researchers, clinicians, and advocates about misuse, unpredictable potency, and emerging health risks. Even though kratom is widely available, there’s still limited public understanding of how synthetic and concentrated 7-OH